AI assistant
Novonesis AS Share Issue/Capital Change 2016
3377_rns_2016-03-30_ab041422-3b9c-430b-9c91-c0ae9c7e8b95.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Reduction of common stock
With reference to company announcement no. 8/2016, a reduction of the company's B common stock by DKK 6,000,000 via cancellation of 3,000,000 treasury B stocks, was adopted at Novozymes A/S' Annual Shareholders' Meeting on February 24, 2016.
The statutory notice expired on March 29, 2016, without any objections being received. Consequently, the reduction of Novozymes' B common stock from DKK 518,512,800 to DKK 512,512,800 has been completed with the Danish Business Authority.
After the reduction, the common stock is DKK 620,000,000, distributed on 310 million stocks of DKK 2 per stock.
| Common stock overview | Common stock, DKK | Number of stocks, DKK 2 |
|---|---|---|
| A common stock | 107,487,200 | 53,743,600 |
| B common stock | 512,512,800 | 256,256,400 |
| Total | 620,000,000 | 310,000,000 |
As communicated in company announcement no. 6, 2015, Novo A/S intends to reduce its relative holding of Novozymes B common stock so that it will continue to hold around 25.5% of the total common stock following Novozymes' cancellation of 3,000,000 treasury B shares.
On March 30, 2016, following the reduction of its common stock, Novozymes' holding of treasury shares were 7.61 million B shares, equivalent to 2.4% of the reduced total share capital.
March 30, 2016
Company announcement No. 15
Contact information
[email protected]
Martin Riise
+45 3077 0738
[email protected]
Klaus Sindahl (DK)
+45 5363 0134
[email protected]
Nicolai Agerskov Kobborg
[email protected]
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27
Rethink Tomorrow
Novozymes